Switch to:
More From Other Websites
Immune Cell Cancer Immunotherapy Passes First Safety Test in Solid Tumors Apr 19 2015
Novartis and Momenta Get FDA Nod For Generic Copaxone - Analyst Blog Apr 17 2015
FDA approves generic version of top-selling MS drug Copaxone Apr 17 2015
FDA approves generic version of top-selling MS drug Copaxone Apr 17 2015
Maverick Capital Increases Stake in Novartis Apr 17 2015
Momenta Pharmaceuticals Inc. (MNTA) in Focus: Stock Jumps 6.1% - Tale of the Tape Apr 17 2015
[video]Buy These 4 High-Yield Dividend Stocks to Take Advantage of the Health Care Boom Apr 17 2015
Aduro Biotech Establishes Major Collaboration with Novartis for Global Research, Development and... Apr 17 2015
Pfizer's Ibrance Study Stopped Early on Favorable Data - Analyst Blog Apr 16 2015
Bristol-Myers Deal Flags Three Gene-Therapy Picks Apr 16 2015
Momenta, Novartis Win FDA Nod For Generic Copaxone Apr 16 2015
FDA approves first generic version of Teva MS drug Copaxone Apr 16 2015
Exclusive: GlaxoSmithKline shutting Moon office; 274 employees affected Apr 16 2015
Sandoz receives FDA approval for GlatopaTM as the first generic competitor to MS therapy Copaxone®... Apr 16 2015
Receptos MS Drug Succeeds Against Ulcerative Colitis Apr 16 2015
FDA approves new type of heart failure drug from Amgen Apr 15 2015
FDA approves new type of heart failure drug from Amgen Apr 15 2015
Biotech IPOs Ignite As Aduro Doubles On First Day Apr 15 2015
Pfizer, Biogen, AbbVie Get Good Drug-Trial News Apr 15 2015
3 Biotech Stocks Under $10 with Amazing Growth Prospects - Analyst Blog Apr 15 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK